Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients:
- People aged 50 or older
- People who have a primary caregiver — someone who regularly helps care for them and who is able to take part in the study alongside them
- People who understand what the study involves and are able to give their formal written agreement to participate
For caregivers:
- People who have been the main caregiver for the patient for at least six months
- People aged 18 or older
- People who understand what the study involves and are able to give their formal written agreement to participate
Who may not be able to join:
For patients:
- People under the age of 50
- People who have a history of serious brain or nervous system conditions (such as severe stroke, brain tumours, or brain injuries that have affected memory or thinking), or a degenerative brain disease
- People with a history of major mental health conditions (such as schizophrenia, severe bipolar disorder, or untreated serious depression), or a history of alcohol or drug misuse
- People with serious medical conditions that may affect memory or thinking (such as advanced kidney or liver failure, severe breathing disorders, untreated underactive thyroid, or vitamin B12 deficiency)
- People with unstable, serious physical health conditions affecting major organs
- People with significant hearing or vision problems, or difficulties with language
- People who have taken part in a clinical trial involving anti-amyloid drugs or other experimental treatments for Alzheimer's disease in the past six months
For caregivers:
- People with a serious active mental health condition (such as untreated severe depression, a psychotic disorder, or schizophrenia)
- People who would have difficulty taking part in interviews or assessments due to language barriers, cognitive difficulties, or other personal limitations
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 0385247268
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mini Mental State Examination (MMSE); Montreal Cognitive Assessment (MoCA); Mental Deterioration Battery (MDB); Free and Cue Selective Reminding Test (FCSRT); Frontal Assessment Battery (FAB); Digit Span forward-backward; Span di cubi forward-backward; Phonemic fluency; Semantic fluency; Trail Making Test (TMT) A-B; Stroop test; Rey-Osterrieth Complex figure (ROCF); Multiple Features Target Target Cancellation; Clock Drawing Test (CDT); Naming of colored photographs; Episodic Memory Score; Semantic-Phonological Delta; Patient Health Questionnaire 9 (PHQ-9); Generalized Anxiety Disorder (GAD-7)...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.